GLP-1 receptor agonists may improve outcomes for patients receiving cancer immunotherapy
30 October 2026
New research suggests that GLP-1 receptor agonists (GLP-1 RAs), commonly used for weight management, may be associated with improved outcomes in patients with overweight or obesity starting ICI therapy… Read More…









